Delivery Order 36F79718D0403-15B50526F00000179
Award Date 7/1/26
Potential Completion Date 7/31/26
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Basking Ridge, Bernards, NJ, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on June 1, 2026, for TURALIO 125mg (pexidartinib), 120-count oral capsules, with ultimate completion by June 30, 2026. The order was placed under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Basking Ridge, New Jersey. Daiichi Sankyo supplies this specialized medication—indicated for treatment of tenosynovial giant cell tumor—to VA healthcare facilities within Veterans...
- Daiichi Sankyo, Inc. was awarded a delivery order valued at $22.1K by Federal Medical Center Carswell for the supply of TURALIO 125mg capsules (120 count) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). The contract represents a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and no set-aside designation was utilized. The product will be delivered to Basking Ridge, New Jersey, and represents one of several delivery orders the vendor has...
- Daiichi Sankyo, Inc. received a delivery order award from the Federal Medical Center Carswell valued at $22,061.05 for the supply of TURALIO 125mg capsules (120-count) with a completion date of December 31, 2025. The contract is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and was issued without a set-aside designation. The products will be delivered to Basking Ridge, New Jersey. Daiichi Sankyo specializes in pharmaceutical...
- This delivery order awards $22.73M to Daiichi Sankyo, Inc. for the supply of TURALIO (pexidartinib) 125mg capsules in 120-count bottles, with an ultimate completion date of January 31, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and funded by Federal Medical Center Carswell, a civilian facility within the Department of Veterans Affairs. Daiichi Sankyo will perform the...
- This delivery order, valued at $22.7K, awards Daiichi Sankyo, Inc. a supply contract for TURALIO (pexidartinib) 125mg in 120-count bottles to support the Federal Medical Center Carswell, a civilian medical facility within the Department of Veterans Affairs system. The award is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Performance will be completed by March 31, 2026, with the award date of...
- Daiichi Sankyo, Inc. was awarded a delivery order valued at $48,124.16 by Veterans Integrated Service Network 20 (VISN 20), part of the Department of Veterans Affairs, on January 20, 2025. The contract, which carries a firm fixed-price structure with no set-aside designation, covers the supply of TURALIO (pexidartinib) pharmaceutical products for delivery to a location in Cary, North Carolina, with a completion deadline of September 30, 2025. This delivery order falls under the GSA...
- This is a federal contract award to Daiichi Sankyo, Inc., a pharmaceutical manufacturer, for the supply of TURALIO 125mg capsules. The contract, valued at $208,538.07, is a delivery order contract with a firm fixed price and was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20. The contract has an ultimate completion date of September 30, 2026. Daiichi Sankyo, Inc. is the prime contractor, and the contract is not a set-aside. The company...
- On January 15, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order valued at $38,097.52 to Takeda Pharmaceuticals America Inc. for TAKHZYRO 150 MG, a specialized pharmaceutical product used to treat rare genetic disorders. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not utilize a set-aside...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Tavalisse 100 mg tablets (60-count unit) with a ceiling value of $10,439.07 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 22, 2026. This delivery order was issued on a non-competitive, no-set-aside basis and calls against AmerisourceBergen's parent company Cencora, Inc.'s Defense Logistics Agency Troop Support...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $27,913.44 order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has an ultimate completion date of August 19, 2024. The order is for the delivery of emergency pharmaceutical products,...